Cas:617-57-2 2-(2-hydroxypropanoyloxy)propanoic acid manufacturer & supplier

Chemical Name:2-(2-hydroxypropanoyloxy)propanoic acid

CAS.NO:617-57-2

Synonyms:Lactic acid dimer;Lactic acid lactate;2-Lactoyloxy-propionsaeure;Lactylmilchsaeure;2-lactoyloxypropionic acid;Milchsaeureanhydrid;Propanoic acid,2-hydroxy-,1-carboxyethyl ester;lactyllactic acid

Molecular Formula:C₆H₁₀O₅

Molecular Weight:162.14100

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:251.1ºC at 760 mmHg

Density:1.308g/cm3

Index of Refraction:1.47

PSA:83.83000

Exact Mass:162.05300

LogP:

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Lactic acid dimer chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,lactyllactic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,lactyllactic acid Use and application,Propanoic acid,2-hydroxy-,1-carboxyethyl ester technical grade,usp/ep/jp grade.

Related News: By drawing these distinctions between APIs and the drugs themselves, manufacturers are able to specialize and pharmacists able to align generic equivalents with brand names. 2-(2-hydroxypropanoyloxy)propanoic acid manufacturer The on-body wear is similar to that of an insulin pump. Unlike insulin pump therapy, however, the investigational system is designed such that users enter only their body weight for the iLet to initialize therapy. 2-(2-hydroxypropanoyloxy)propanoic acid supplier By drawing these distinctions between APIs and the drugs themselves, manufacturers are able to specialize and pharmacists able to align generic equivalents with brand names. 2-(2-hydroxypropanoyloxy)propanoic acid vendor The on-body wear is similar to that of an insulin pump. Unlike insulin pump therapy, however, the investigational system is designed such that users enter only their body weight for the iLet to initialize therapy. 2-(2-hydroxypropanoyloxy)propanoic acid factory As a result, the Company��s platform is uniquely capable of overcoming numerous limitations associated with the production of cell therapies using patient- or donor-sourced cells, which is logistically complex and expensive and is subject to batch-to-batch and cell-to-cell variability that can affect clinical safety and efficacy.